Chemicals · Founded 1969 · www.pidilite.com · BSE 500331 · NSE PIDILITE · ISIN INE318A01026
No Notes Added Yet
1. Business Overview
Pidilite Industries Ltd. is an Indian specialty chemicals company, primarily engaged in the manufacturing and marketing of adhesives, sealants, construction chemicals, art materials, industrial resins, and organic pigment powders. Its core business model revolves around developing and marketing innovative products, primarily under strong consumer brands like Fevicol, Fevikwik, Dr. Fixit, M-Seal, and Fevicryl. The company makes money by selling these products through an extensive distribution network across B2C (Consumer & Bazaar) and B2B (Industrial Products) channels, leveraging brand loyalty and product quality to command premium pricing in many segments.
2. Key Segments / Revenue Mix
Pidilite primarily operates through two main segments:
Consumer & Bazaar (C&B): This is the dominant segment and includes products sold directly to end-consumers and small contractors. Key brands include Fevicol (adhesives), Fevikwik (instant adhesives), Dr. Fixit (waterproofing solutions), M-Seal (epoxy compounds), Fevicryl (art materials), and Hobby Ideas. This segment is characterized by strong brand recall, extensive distribution, and higher margins.
Industrial Products: This segment caters to industrial clients with products such as industrial adhesives, industrial resins, construction chemicals (specific formulations for large projects), and organic pigment powders. While significant, it generally represents a smaller portion of the overall revenue compared to the C&B segment.
(Note: Specific revenue contributions are not provided here as per instruction to not fabricate numbers, but C&B is widely known to be the larger and more profitable segment).
3. Industry & Positioning
Pidilite operates primarily in the specialty chemicals sector, particularly dominating segments like consumer adhesives, instant adhesives, and a significant portion of construction chemicals in India. The Indian adhesives market, while having some fragmented and unorganized players, sees Pidilite as the undisputed market leader in the organized consumer segment. In construction chemicals, it competes with both domestic and international players but holds a strong position, especially in the waterproofing category. Its extensive distribution network, reaching even smaller towns and rural areas, gives it a significant competitive edge over most peers.
4. Competitive Advantage (Moat)
Pidilite possesses several durable competitive advantages:
Strong Brand Equity: Brands like "Fevicol" and "Fevikwik" have become almost generic terms for adhesives in India, enjoying high consumer trust and recall. "Dr. Fixit" has similarly established itself in waterproofing. This allows for pricing power and customer loyalty.
Extensive Distribution Network: Pidilite has built a deep and wide distribution network across India, enabling its products to reach diverse geographies, including rural and semi-urban markets, which is difficult and costly for competitors to replicate.
Market Leadership & Scale: Dominant market share in key segments provides economies of scale in manufacturing, procurement, and advertising, reinforcing its leadership position.
Product Innovation: Consistent focus on R&D and new product development helps the company maintain relevance and enter new adjacent categories.
5. Growth Drivers
Urbanization and Construction Growth: Increasing demand for construction chemicals, tile adhesives, and waterproofing solutions driven by rising infrastructure development, real estate activity, and home renovation.
Rising Disposable Incomes: Higher discretionary spending on home improvement, DIY projects, and art & craft activities.
Shift from Unorganized to Organized Sector: Consumers and professionals increasingly prefer branded, quality products over unorganized alternatives.
Penetration in Tier 2/3 Cities and Rural Markets: Expansion of sales and distribution into untapped geographies.
Product Portfolio Expansion & Innovation: Launch of new products and variants within existing categories and venturing into adjacent categories.
International Expansion: Gradual growth in select overseas markets, particularly emerging economies.
6. Risks
Raw Material Price Volatility: Key raw materials, primarily crude oil derivatives (e.g., VAM – Vinyl Acetate Monomer), are susceptible to global price fluctuations, which can impact profit margins.
Competition: Increasing competition from domestic and international players in both consumer and industrial segments, potentially leading to pricing pressure.
Economic Slowdown: A downturn in the economy can impact discretionary spending on home improvement and slow down construction activity, affecting demand for Pidilite's products.
Currency Fluctuations: For imported raw materials and international business operations.
Regulatory Changes: Potential changes in environmental regulations or taxation policies could impact operations and costs.
7. Management & Ownership
Pidilite Industries Ltd. was founded by Balvantsingh Parekh. The company continues to be driven by its promoter family, with strong promoter holding. The management is generally regarded as professional, visionary, and focused on long-term brand building, innovation, and sustainable growth. The ownership structure includes a significant promoter stake, complemented by holdings from institutional investors (domestic and foreign) and the public.
8. Outlook
Pidilite Industries possesses a robust business model characterized by dominant market leadership in key segments, strong brand equity, and an unparalleled distribution network in India. The company is well-positioned to benefit from India's long-term growth trends in construction, infrastructure development, and rising consumer discretionary spending. Its consistent focus on innovation and brand building provides a strong moat. However, the business is susceptible to volatility in raw material prices, which can impact margins, and faces ongoing competition. While Pidilite has demonstrated resilience and pricing power historically, its ability to navigate cost pressures while maintaining market share and expanding into new categories will be crucial for sustained performance.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 3130 | 2902 | 3395 | 3235 | 3369 | 3141 | 3753 | 3554 | 3710 | 3583 |
| Other Income | 37 | 49 | 54 | 57 | 56 | 80 | 86 | 50 | 66 | 65 |
| Total Income | 3167 | 2951 | 3449 | 3292 | 3425 | 3222 | 3839 | 3605 | 3775 | 3648 |
| Total Expenditure | 2388 | 2325 | 2583 | 2466 | 2571 | 2509 | 2812 | 2704 | 2815 | 2751 |
| Operating Profit | 779 | 626 | 867 | 826 | 854 | 713 | 1027 | 901 | 960 | 898 |
| Interest | 13 | 13 | 12 | 12 | 12 | 14 | 14 | 13 | 13 | 14 |
| Depreciation | 79 | 113 | 84 | 88 | 90 | 97 | 97 | 100 | 101 | 97 |
| Exceptional Income / Expenses | 0 | -72 | 0 | 0 | 0 | -25 | 0 | 0 | -6 | -8 |
| Profit Before Tax | 687 | 428 | 770 | 726 | 752 | 577 | 916 | 788 | 840 | 779 |
| Provision for Tax | 177 | 122 | 198 | 185 | 195 | 149 | 238 | 203 | 216 | 193 |
| Profit After Tax | 511 | 306 | 572 | 542 | 558 | 428 | 678 | 585 | 624 | 586 |
| Adjustments | -0 | -6 | -5 | -7 | -5 | -6 | -5 | -6 | -6 | -7 |
| Profit After Adjustments | 510 | 301 | 567 | 535 | 552 | 422 | 672 | 579 | 618 | 579 |
| Adjusted Earnings Per Share | 5 | 3 | 5.6 | 5.3 | 5.4 | 4.2 | 6.6 | 5.7 | 6.1 | 5.7 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 4844 | 5361 | 5617 | 6078 | 7078 | 7294 | 7293 | 9921 | 11799 | 12383 | 13140 | 14600 |
| Other Income | 45 | 78 | 112 | 148 | 147 | 149 | 79 | 36 | 50 | 140 | 247 | 267 |
| Total Income | 4890 | 5439 | 5729 | 6227 | 7225 | 7444 | 7372 | 9957 | 11849 | 12523 | 13388 | 14867 |
| Total Expenditure | 4073 | 4188 | 4357 | 4737 | 5710 | 5718 | 5612 | 8074 | 9815 | 9676 | 10128 | 11082 |
| Operating Profit | 816 | 1251 | 1372 | 1490 | 1515 | 1725 | 1760 | 1884 | 2034 | 2847 | 3260 | 3786 |
| Interest | 16 | 13 | 14 | 16 | 26 | 34 | 37 | 42 | 48 | 51 | 50 | 54 |
| Depreciation | 118 | 100 | 115 | 120 | 133 | 170 | 201 | 240 | 270 | 341 | 358 | 395 |
| Exceptional Income / Expenses | -5 | 0 | 0 | 0 | -18 | -55 | -4 | 0 | 0 | -72 | -25 | -14 |
| Profit Before Tax | 678 | 1141 | 1248 | 1359 | 1342 | 1470 | 1522 | 1614 | 1723 | 2379 | 2823 | 3323 |
| Provision for Tax | 169 | 334 | 385 | 393 | 413 | 348 | 396 | 407 | 434 | 632 | 727 | 850 |
| Profit After Tax | 509 | 807 | 863 | 966 | 928 | 1122 | 1126 | 1207 | 1289 | 1747 | 2096 | 2473 |
| Adjustments | 4 | -4 | -3 | -4 | -3 | -6 | 5 | 1 | -16 | -18 | -20 | -24 |
| Profit After Adjustments | 513 | 803 | 860 | 962 | 925 | 1116 | 1131 | 1208 | 1273 | 1729 | 2076 | 2448 |
| Adjusted Earnings Per Share | 5 | 7.8 | 8.4 | 9.5 | 9.1 | 11 | 11.1 | 11.9 | 12.5 | 17 | 20.4 | 24.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 6% | 10% | 12% | 10% |
| Operating Profit CAGR | 15% | 20% | 14% | 15% |
| PAT CAGR | 20% | 20% | 13% | 15% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -1% | 5% | 8% | 16% |
| ROE Average | 23% | 22% | 21% | 25% |
| ROCE Average | 31% | 29% | 29% | 33% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 2271 | 2638 | 3471 | 3574 | 4148 | 4456 | 5593 | 6404 | 7212 | 8407 | 9754 |
| Minority's Interest | 5 | 43 | 127 | 175 | 207 | 216 | 240 | 199 | 234 | 210 | 203 |
| Borrowings | 1 | 6 | 5 | 7 | 9 | 25 | 12 | 2 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 80 | 112 | 145 | 234 | 239 | 212 | 534 | 565 | 648 | 661 | 736 |
| Total Current Liabilities | 959 | 915 | 1022 | 1208 | 1301 | 1615 | 2435 | 2325 | 2411 | 2798 | 3290 |
| Total Liabilities | 3315 | 3714 | 4770 | 5199 | 5904 | 6523 | 8814 | 9494 | 10505 | 12076 | 13984 |
| Fixed Assets | 978 | 1137 | 1275 | 1342 | 1448 | 1807 | 4418 | 4703 | 4914 | 5451 | 5705 |
| Other Non-Current Assets | 666 | 425 | 361 | 548 | 874 | 955 | 881 | 775 | 1029 | 789 | 816 |
| Total Current Assets | 1671 | 2151 | 3134 | 3309 | 3582 | 3761 | 3515 | 4016 | 4562 | 5833 | 7462 |
| Total Assets | 3315 | 3714 | 4770 | 5199 | 5904 | 6523 | 8814 | 9494 | 10505 | 12076 | 13984 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 118 | 56 | 100 | 55 | 102 | 73 | 606 | 327 | 256 | 258 | 459 |
| Cash Flow from Operating Activities | 552 | 907 | 794 | 796 | 845 | 1280 | 1392 | 955 | 1558 | 2724 | 2287 |
| Cash Flow from Investing Activities | -436 | -491 | -879 | 39 | -513 | 103 | -1688 | -558 | -899 | -1769 | -1542 |
| Cash Flow from Financing Activities | -165 | -371 | 41 | -790 | -361 | -849 | -76 | -468 | -656 | -742 | -918 |
| Net Cash Inflow / Outflow | -49 | 45 | -45 | 46 | -29 | 533 | -372 | -71 | 2 | 212 | -173 |
| Closing Cash & Cash Equivalent | 69 | 101 | 56 | 102 | 73 | 606 | 327 | 256 | 258 | 459 | 287 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 5 | 7.83 | 8.39 | 9.48 | 9.1 | 10.99 | 11.13 | 11.88 | 12.52 | 17 | 20.41 |
| CEPS(Rs) | 6.11 | 8.85 | 9.54 | 10.69 | 10.44 | 12.71 | 13.05 | 14.23 | 15.33 | 20.53 | 24.13 |
| DPS(Rs) | 1.45 | 2.08 | 2.38 | 3 | 3.25 | 3.5 | 4.25 | 5 | 5.5 | 8 | 10 |
| Book NAV/Share(Rs) | 22.14 | 25.69 | 33.74 | 35.1 | 40.73 | 43.74 | 54.78 | 62.67 | 70.52 | 82.55 | 95 |
| Core EBITDA Margin(%) | 15.02 | 20.58 | 20.78 | 21.57 | 19.33 | 21.61 | 23.05 | 18.62 | 16.82 | 21.86 | 22.93 |
| EBIT Margin(%) | 13.51 | 20.24 | 20.82 | 22.1 | 19.32 | 20.61 | 21.39 | 16.69 | 15.01 | 19.63 | 21.86 |
| Pre Tax Margin(%) | 13.21 | 20.01 | 20.59 | 21.85 | 18.95 | 20.15 | 20.88 | 16.27 | 14.6 | 19.21 | 21.48 |
| PAT Margin (%) | 9.91 | 14.16 | 14.24 | 15.54 | 13.12 | 15.38 | 15.44 | 12.16 | 10.92 | 14.11 | 15.95 |
| Cash Profit Margin (%) | 12.2 | 15.92 | 16.14 | 17.46 | 14.99 | 17.71 | 18.19 | 14.58 | 13.21 | 16.86 | 18.68 |
| ROA(%) | 16.29 | 22.97 | 20.35 | 19.38 | 16.72 | 18.06 | 14.69 | 13.18 | 12.89 | 15.48 | 16.09 |
| ROE(%) | 24.09 | 32.92 | 28.33 | 27.5 | 24.1 | 26.15 | 22.5 | 20.22 | 19.04 | 22.45 | 23.21 |
| ROCE(%) | 32.05 | 45.73 | 40.16 | 37.82 | 34.37 | 33.81 | 29.86 | 26.48 | 25.18 | 30.55 | 31.16 |
| Receivable days | 39.48 | 41.22 | 44.26 | 50.09 | 51.42 | 53.65 | 60.3 | 50.62 | 45.87 | 47.31 | 48.41 |
| Inventory Days | 44.11 | 40.6 | 40.59 | 44.76 | 44.83 | 46.63 | 54.14 | 53.88 | 54.32 | 47.63 | 43.05 |
| Payable days | 46.46 | 49.84 | 52.84 | 59.04 | 57.22 | 64.45 | 87.98 | 68.92 | 57.05 | 67.32 | 77.23 |
| PER(x) | 60.1 | 37.79 | 41.66 | 48.47 | 68.24 | 61.74 | 81.31 | 103.35 | 93.97 | 88.66 | 69.8 |
| Price/Book(x) | 13.57 | 11.52 | 10.36 | 13.08 | 15.25 | 15.51 | 16.52 | 19.59 | 16.69 | 18.26 | 15 |
| Dividend Yield(%) | 0.48 | 0.7 | 0.68 | 0.65 | 0.52 | 0.52 | 0.47 | 0.41 | 0.47 | 0.53 | 0.7 |
| EV/Net Sales(x) | 6.36 | 5.65 | 6.38 | 7.67 | 8.91 | 9.38 | 12.58 | 12.57 | 10.13 | 12.35 | 11.01 |
| EV/Core EBITDA(x) | 37.72 | 24.2 | 26.11 | 31.28 | 41.61 | 39.64 | 52.13 | 66.22 | 58.74 | 53.72 | 44.4 |
| Net Sales Growth(%) | 13.1 | 10.67 | 4.77 | 8.22 | 16.44 | 3.06 | -0.02 | 36.04 | 18.93 | 4.95 | 6.12 |
| EBIT Growth(%) | 10.33 | 66.39 | 9.37 | 8.88 | -0.48 | 9.92 | 3.75 | 6.16 | 6.95 | 37.25 | 18.21 |
| PAT Growth(%) | 13.75 | 58.74 | 6.94 | 11.92 | -3.9 | 20.86 | 0.36 | 7.16 | 6.8 | 35.58 | 19.96 |
| EPS Growth(%) | 13.95 | 56.62 | 7.12 | 12.98 | -3.93 | 20.68 | 1.3 | 6.73 | 5.44 | 35.74 | 20.06 |
| Debt/Equity(x) | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.02 | 0.02 | 0.02 |
| Current Ratio(x) | 1.74 | 2.35 | 3.07 | 2.74 | 2.75 | 2.33 | 1.44 | 1.73 | 1.89 | 2.09 | 2.27 |
| Quick Ratio(x) | 1.07 | 1.67 | 2.36 | 2.07 | 2.04 | 1.75 | 0.94 | 1 | 1.14 | 1.58 | 1.76 |
| Interest Cover(x) | 44.34 | 86.97 | 90.61 | 88.44 | 52.46 | 44.74 | 41.89 | 39.35 | 37.17 | 47.48 | 57.06 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.84 | 69.77 | 69.75 | 69.6 | 69.6 | 69.5 | 69.36 | 69.33 | 69.33 | 69.32 |
| FII | 11.49 | 11.31 | 11.58 | 11.96 | 11.79 | 11.6 | 12.13 | 12.09 | 12 | 11.75 |
| DII | 8.31 | 8.93 | 8.97 | 8.9 | 9.15 | 9.42 | 9.15 | 9.15 | 9.25 | 9.63 |
| Public | 10.35 | 9.99 | 9.7 | 9.54 | 9.47 | 9.48 | 9.36 | 9.44 | 9.42 | 9.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 35.52 | 35.49 | 35.48 | 35.4 | 35.4 | 35.35 | 35.28 | 70.56 | 70.56 | 70.55 |
| FII | 5.85 | 5.75 | 5.89 | 6.08 | 6 | 5.9 | 6.17 | 12.3 | 12.21 | 11.96 |
| DII | 4.23 | 4.54 | 4.56 | 4.53 | 4.65 | 4.79 | 4.65 | 9.31 | 9.42 | 9.8 |
| Public | 5.27 | 5.08 | 4.93 | 4.85 | 4.82 | 4.82 | 4.76 | 9.6 | 9.58 | 9.47 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 50.86 | 50.86 | 50.86 | 50.86 | 50.86 | 50.86 | 50.86 | 101.77 | 101.77 | 101.78 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.84 | 69.77 | 69.75 | 69.6 | 69.6 | 69.5 | 69.36 | 69.33 | 69.33 | 69.32 |
| FII | 11.49 | 11.31 | 11.58 | 11.96 | 11.79 | 11.6 | 12.13 | 12.09 | 12 | 11.75 |
| DII | 8.31 | 8.93 | 8.97 | 8.9 | 9.15 | 9.42 | 9.15 | 9.15 | 9.25 | 9.63 |
| Public | 30.16 | 30.23 | 30.25 | 30.4 | 30.4 | 30.5 | 30.64 | 30.67 | 30.67 | 30.68 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 35.52 | 35.49 | 35.48 | 35.4 | 35.4 | 35.35 | 35.28 | 70.56 | 70.56 | 70.55 |
| FII | 5.85 | 5.75 | 5.89 | 6.08 | 6 | 5.9 | 6.17 | 12.3 | 12.21 | 11.96 |
| DII | 4.23 | 4.54 | 4.56 | 4.53 | 4.65 | 4.79 | 4.65 | 9.31 | 9.42 | 9.8 |
| Public | 15.34 | 15.37 | 15.38 | 15.46 | 15.46 | 15.52 | 15.59 | 31.21 | 31.21 | 31.23 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 50.86 | 50.86 | 50.86 | 50.86 | 50.86 | 50.86 | 50.86 | 101.77 | 101.77 | 101.78 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +6% | +10% | +12% | +10% |
| Operating Profit CAGR | +15% | +20% | +14% | +15% |
| PAT CAGR | +20% | +20% | +13% | +15% |
| Share Price CAGR | -1% | +5% | +8% | +16% |
| ROE Average | +23% | +22% | +21% | +25% |
| ROCE Average | +31% | +29% | +29% | +33% |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.